ArticleAdvances in cell and gene therapy2025

Long-Term Correction of Murine Glycogen Storage Disease Type III by AAV-Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial Pullulanase.

Kuo-An Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.